Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1169 studies found for:    EGF
Show Display Options
Rank Status Study
1 Recruiting Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: EGF Vaccine
2 Recruiting Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
Conditions: Drug-Related Side Effects and Adverse Reactions;   Epidermal Growth Factor
Interventions: Drug: Repair Control EGF®;   Drug: Cream without rhEGF
3 Recruiting Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
Conditions: Drug-Related Side Effects and Adverse Reactions;   Epidermal Growth Factor
Interventions: Drug: Repair Control EGF®;   Drug: Cream without rhEGF
4 Recruiting Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: EGF816;   Drug: INC280;   Drug: Nivolumab
5 Recruiting Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Conditions: Non-small Cell Lung Cancer;   Pancreatic Cancer;   Colorectal Cancer
Interventions: Drug: Arm 1;   Drug: Arm 2
6 Completed EGF Ointment for Erlotinib Skin Lesion
Conditions: Non-small Cell Lung Cancer;   Pancreatic Cancer
Intervention: Drug: Epidermal growth factor (EGF) ointment
7 Completed ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer;   Neoplasm Metastasis;   Lung Cancer
Intervention: Drug: ABX-EGF
8 Completed
Has Results
ABX-EGF (Panitumumab) Monotherapy in Subjects With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer;   Metastases
Intervention: Drug: ABX-EGF (panitumumab)
9 Terminated A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: Therapeutic EGF Vaccine (Cyclophosphamide and the recombinant human rEGF-P64K/Montanide ISA 51 vaccine)
10 Recruiting A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies
Condition: Advanced Non-small Cell Lung Cancer
Intervention: Drug: EGF816
11 Completed Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
Conditions: Colorectal Cancer;   Carcinoma
Intervention: Drug: ABX-EGF
12 Completed ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body
Condition: Prostate Cancer
Intervention: Drug: ABX-EGF
13 Recruiting Study of Safety and Efficacy of EGF816 in Combination With INC280 in Non-small Cell Lung Cancer Patients With EGFR Mutation.
Condition: Non Small Cell Lung Cancer
Interventions: Drug: INC280;   Drug: EGF816
14 Completed Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: ABX-EGF
15 Unknown  A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF
Condition: Plaque Psoriasis
Interventions: Drug: Human recombinant epidermal growth factor;   Other: Placebo cream
16 Completed Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: ABX-EGF (panitumumab)
17 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer;   Metastases
Interventions: Other: Best supportive care;   Drug: Panitumumab
18 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Biological: Panitumumab;   Drug: 5-Fluorouracil;   Drug: Leucovorin
19 Completed
Has Results
Effect of EGF With Silver Sulfadiazine Cream Compared With Silver Zinc Sulfadiazine Cream for Treatment of Burn Wound
Condition: Deep Partial Thickness Burn
Interventions: Drug: Epidermal growth factor with silver sulfadiazine cream;   Drug: Silver zinc sulfadiazine cream
20 Completed Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis
Conditions: Gastroesophageal Reflux Disease (GERD);   Chronic Laryngitis
Intervention: Drug: omeprazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.